<p>Pfizer CEO Albert Bourla on Thursday said he was against a US-backed proposal to waive patents on Covid-19 vaccines, saying production should be ramped up in existing facilities instead.</p>.<p><strong>Also Read: <a href="https://www.deccanherald.com/international/explained-how-the-us-waiving-ip-rights-could-pave-way-for-a-people-s-vaccine-982946.html" target="_blank">Explained | How the US waiving IP rights could pave way for a 'people’s vaccine'</a></strong></p>.<p>In an interview with <em>AFP</em>, Bourla said his company, which developed its vaccine with German firm BioNTech, was "not at all" in favour of the call from the United States to waive patent protections for coronavirus jabs.</p>
<p>Pfizer CEO Albert Bourla on Thursday said he was against a US-backed proposal to waive patents on Covid-19 vaccines, saying production should be ramped up in existing facilities instead.</p>.<p><strong>Also Read: <a href="https://www.deccanherald.com/international/explained-how-the-us-waiving-ip-rights-could-pave-way-for-a-people-s-vaccine-982946.html" target="_blank">Explained | How the US waiving IP rights could pave way for a 'people’s vaccine'</a></strong></p>.<p>In an interview with <em>AFP</em>, Bourla said his company, which developed its vaccine with German firm BioNTech, was "not at all" in favour of the call from the United States to waive patent protections for coronavirus jabs.</p>